Protected PCI: Current Data and Best Practices in High-Risk Patients
In this roundtable discussion, Dr. John Lasala of Washington University in St. Louis interviews Dr. Bill O’Neill (Henry Ford Hospital, Detroit, MI), Dr. Bill Lombardi (University of Washington, Seattle, WA), and Dr. Jeff Moses (Columbia University, New York, NY) on the current data regarding high-risk patients undergoing Protected PCI. During this interview, Dr. Moses provides an extensive overview of Protected PCI indications, while Dr. Lombardi provides his insight into the importance of maintaining hemodynamic stability in high-risk PCI.
The team also discusses the advantages of complete revascularization and approaches to specific anatomical challenges, such as chronic total occlusions, during a Protected PCI procedure. Finally, Dr. O’Neill discusses the results of the PROTECT II trial in comparison to findings from the SYNTAX trial.
- John Mulder, PA-C of Spectrum Health Explains What Protected PCI Means to Him
- High-Risk PCI and Revascularization: Heart Team Decision-Making
To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: abiomed.com/important-safety-information